VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.
Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC.
Stojdl DF, et al. Among authors: lichty bd.
Cancer Cell. 2003 Oct;4(4):263-75. doi: 10.1016/s1535-6108(03)00241-1.
Cancer Cell. 2003.
PMID: 14585354
Free article.